Patents for C12P 21 - Preparation of peptides or proteins (112,499)
01/2008
01/01/2008US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of
01/01/2008US7314615 IκB Kinase-β (IKKβ) binding antibodies and methods of using same
01/01/2008US7314613 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells
12/2007
12/27/2007WO2007149327A2 Composition and methods for improving the production of fermentation operations
12/27/2007WO2007149287A2 Transfer factor compositions and methods
12/27/2007WO2007148092A2 In vitro protein expression process comprising cκ fusion molecules
12/27/2007WO2007147256A1 Fatty acid hydroxylases and uses thereof
12/27/2007WO2007070315A3 Improved production of glycoproteins using manganese
12/27/2007WO2007002008A3 Methods and compositions for expressing negative-sense viral rna in canine cells
12/27/2007WO2006138363A3 Method for identifying modulators of keah6 useful for treating alzheimer's disease
12/27/2007WO2005099390A3 Compositions and methods for reverse transcription
12/27/2007WO2005069859A3 Compositions and methods for modulating dhr96
12/27/2007WO2003066824A3 Albumin-fused kunitz domain peptides
12/27/2007US20070299247 Heterodimeric human cytokine receptor comprising interleukin-10 or orphan receptor components for use in treatment of cell proliferative, inflammatory and immune disorders
12/27/2007US20070299014 Casein hydrolyzate, process for producing the same and use thereof
12/27/2007US20070299006 Secreted by yeast; storage stability; nonimmunogenic; vaccine; long half-life; use for growth hormone deficiency in human or animal to stimulate meat production
12/27/2007US20070298493 Transgenic animal cells containing endotheilial growth factor polypeptide for use as model system for treatment of cardiovascular and respiratory system disorders
12/27/2007US20070298463 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
12/27/2007US20070298462 Process for Obtaining Antibodies
12/27/2007US20070298460 Novel receptor that causes cell death
12/27/2007US20070298459 Death Domain Containing Receptor 6; severe combined immunodeficiency (SCID); adenosine deaminase deficiency, agammaglobulinemia Bruton's disease
12/27/2007US20070298458 Method And Kit For Expressing Protein Under Regulation Of The Expression From Repeated Sequence Formed By Gene Amplification, And Transformant
12/27/2007US20070298457 Soluble endoproteases for the in vitro processing of recombinant proteins
12/27/2007US20070298455 Method For Preparing A Modified Host Cell
12/27/2007US20070298448 Enrichment of Enzymatic Cleavage Products
12/27/2007US20070298430 Ribosome Display or Mrna Display Method With Selection for Increased Stability of the Protein
12/27/2007US20070298418 Molecules Involved in Protein Folding
12/27/2007US20070298050 direct replacement of chloroplast Photosystem II (PSII) reaction center protein coding regions to achieve expression of recombinant protein above 5% of total protein; edible algae; mammary associated serum amyloid A3 (M-SAA3)
12/27/2007US20070298049 Therapeutic Agent for Polycystic Ovary Syndrome (Pcos)
12/27/2007US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
12/27/2007US20070298036 PRO71238 Polypeptides
12/27/2007US20070298034 Sulfotyrosine specific antibodies and uses therefor
12/27/2007DE202007012343U1 Aminosäure-Mineral-Peptid-Komplex, insbesondere quantenmechanisch modifiziert, als Rezeptur zur Regulierung der Haut Amino acid-mineral-peptide complex, in particular quantum-mechanically modified, as formulation for regulating skin
12/27/2007CA2655544A1 Fatty acid hydroxylases and uses thereof
12/27/2007CA2653061A1 Stabilized proteins
12/26/2007EP1870467A1 Polypeptide hormone Phosphatonin
12/26/2007EP1870466A2 Compositions and methods for therapy and diagnosis of prostate cancer
12/26/2007EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies
12/26/2007EP1870460A1 Methods of producing proteins having triple-helix structure
12/26/2007EP1870459A1 Methods for producing polypeptides by regulating polypeptide association
12/26/2007EP1870457A1 Dipeptide crystals and process for production thereof
12/26/2007EP1870456A1 Method for production of antibody directed against cell membrane surface antigen epitope and assaying method
12/26/2007EP1870454A1 Method for producing dipeptide
12/26/2007EP1870421A1 Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate
12/26/2007EP1869230A2 Method for purifying proteins
12/26/2007EP1869192A2 Framework-shuffling of antibodies
12/26/2007EP1869174A2 Lyase enzymes, nucleic acids encoding them and methods for making and using them
12/26/2007EP1869173A2 Hydrolases, nucleic acids encoding them and methods for improving paper strength
12/26/2007EP1868650A2 Covalent diabodies and uses thereof
12/26/2007EP1868647A2 Antibodies that bind ov064 and methods of use therefor
12/26/2007EP1427744B1 A system for antibody expression and assembly
12/26/2007EP1401869B1 Molecules and methods for inhibiting shedding of kim-1
12/26/2007EP1116029B1 Apoptosis marker antibodies and methods of use
12/26/2007EP0517829B2 Improved chimeric toxins
12/26/2007CN101095053A Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84
12/26/2007CN101094916A Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for structure determination
12/26/2007CN101094688A Multimeric constructs
12/26/2007CN101094685A Use of flagellin in the immunotherapy of yersinia pestis
12/26/2007CN101092640A Method for producing tabling monoclonal antibody of anti CD25
12/26/2007CN101092453A Therapeutic compounds comprised of anti-fc receptor binding agents
12/26/2007CN101092446A Methods of synthesizing cell-free protein
12/26/2007CN101091722A Injection of hydrolyzed peptide of liver
12/26/2007CN100357448C Production method for iturin A and its homologues
12/26/2007CN100357441C Yeast expressing system of recombined human nerve growth factor and process for preparing recombined human nerve grouth factor
12/26/2007CN100357430C 纤维蛋白溶解活性多肽 Polypeptide fibrinolytic activity
12/26/2007CN100357318C Mermaid photobacterium envelop protein W and coding sequence , its preparation method and uses
12/25/2007US7312320 Neutralizing antibodies and methods of use thereof
12/25/2007US7312317 P2Y4 antibodies
12/25/2007US7312316 Novel polypeptides and nucleic acid molecules encoding those polypeptides; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, and antibodies which bind to the polypeptides
12/25/2007US7312315 PRO9742 antibodies
12/25/2007US7312314 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
12/25/2007US7312313 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
12/25/2007US7312312 PRO6242 polypeptides
12/25/2007US7312309 For release of tumor necrosis and or cellular differentation/proliferation of chrondrocytes by contacting blood w/polypeptides; cancer diagnosis
12/25/2007US7312308 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
12/25/2007US7312303 Anti-PRO4980 antibodies
12/25/2007US7312192 For treating diseases including diabetes
12/25/2007US7312190 Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
12/25/2007US7312080 Plant resistance to insect pests mediated by viral proteins
12/25/2007US7312079 host cell; expression vector; predicted osteoblast protein; for diagnosis, drug screening, clinical trial monitoring, the treatment of FAM3C-related disorders
12/25/2007US7312060 Non-radioactive markers that facilitate the detection and analysis of nascent proteins translated within cellular or cell-free systems; preferred markers are dipyrrometheneboron difluoride
12/25/2007US7312051 Polynucleotides encoding dendritic enriched secreted lymphocyte activation molecule
12/25/2007US7312050 Nucleic acids encoding interphotoreceptor matrix proteins
12/25/2007US7312049 Total amino acid stabilization during cell-free protein synthesis
12/25/2007US7311918 Generation of rotavirus subunit proteins for use in vaccines and methods of providing protective immunity to vertebrates, including humans, against rotavirus infection or disease; providing cell-mediated immune response
12/25/2007US7311917 Membrane proteins; fusion proteins; vaccines; kits
12/25/2007US7311916 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry
12/25/2007US7311913 humanized monoclonal antibodies against human antihemophilic factor, used as antithrombotic agents, for treatment of strokes, ischemia, angina, necrosis, thrombosis, anemia, urogental disorders, thrombocytopenia or restenosis; cardiovascular disorders
12/25/2007US7311909 PRO4348 antibodies
12/21/2007WO2007145602A1 Process for the preparation of polymyxin b employing ( paeni ) bacillus polymyxa
12/21/2007WO2007145267A1 Promoter capable of being expressed in root of plant
12/21/2007WO2007144475A1 Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses
12/21/2007WO2007143858A1 Dph2 gene deletion mutant and uses thereof
12/21/2007WO2007104019A3 Hybrid protein with cox and pges enzyme activities
12/21/2007WO2007104000A3 Hybrid protein that converts arachidonic acid into prostacyclin
12/21/2007WO2007095243A3 Nucleic acid constructs and methods for producing altered seed oil compositions
12/21/2007WO2007005647A3 Polynucleotides and polypeptides of the il-12 family of cytokines
12/21/2007WO2006099592A3 Mannose immunogens for hiv-1
12/21/2007WO2004094593A3 Expanding the eukaryotic genetic code
12/21/2007WO2004071405A3 Lactate dehydrogenase: a target and reagent for diabetes therapy